<i>FAM64A</i>: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of <i>miR-99a</i> (<i>miR-99a-5p</i> and <i>miR-99a-3p</i>)

by Keiko Mizuno, Kengo Tanigawa, Nijiro Nohata, Shunsuke Misono, Reona Okada, Shunichi Asai, Shogo Moriya, Takayuki Suetsugu, Hiromasa Inoue, Naohiko Seki
Published 2020-09-01

Regulation of <i>KIF2A</i> by Antitumor <i>miR-451a</i> Inhibits Cancer Cell Aggressiveness Features in Lung Squamous Cell Carcinoma

by Akifumi Uchida, Naohiko Seki, Keiko Mizuno, Yasutaka Yamada, Shunsuke Misono, Hiroki Sanada, Naoko Kikkawa, Tomohiro Kumamoto, Takayuki Suetsugu, Hiromasa Inoue
Published 2019-02-01

Molecular Pathogenesis of Gene Regulation by the <i>miR-150</i> Duplex: <i>miR-150-3p</i> Regulates <i>TNS4</i> in Lung Adenocarcinoma

by Shunsuke Misono, Naohiko Seki, Keiko Mizuno, Yasutaka Yamada, Akifumi Uchida, Hiroki Sanada, Shogo Moriya, Naoko Kikkawa, Tomohiro Kumamoto, Takayuki Suetsugu, Hiromasa Inoue
Published 2019-04-01

Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The <i>MCM</i> Complex as Therapeutic Target

by Shunsuke Misono, Keiko Mizuno, Takayuki Suetsugu, Kengo Tanigawa, Nijiro Nohata, Akifumi Uchida, Hiroki Sanada, Reona Okada, Shogo Moriya, Hiromasa Inoue, Naohiko Seki
Published 2021-03-01

High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction

by Takayuki Takahashi, Hideyuki Terazono, Takayuki Suetsugu, Hideki Sugawara, Junko Arima, Mina Nitta, Toru Tanabe, Kayu Okutsu, Ryuji Ikeda, Keiko Mizuno, Hiromasa Inoue, Yasuo Takeda
Published 2021-07-01

Involvement of Dual Strands of <i>miR-143</i> (<i>miR-143-5p</i> and <i>miR-143-3p</i>) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma

by Hiroki Sanada, Naohiko Seki, Keiko Mizuno, Shunsuke Misono, Akifumi Uchida, Yasutaka Yamada, Shogo Moriya, Naoko Kikkawa, Kentaro Machida, Tomohiro Kumamoto, Takayuki Suetsugu, Hiromasa Inoue
Published 2019-09-01

A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK...

by Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, Minoru Fukuda, Masafumi Takeshita, Takayuki Suetsugu, Keisuke Kirita, Noriyuki Ebi, Osamu Hataji, Satoru Miura, Kenji Chibana, Isamu Okamoto, Kenichi Yoshimura, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Kenji Sugio
Published 2020-05-01

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment

by Naoko Sueoka‐Aragane, Chiho Nakashima, Hironori Yoshida, Naohisa Matsumoto, Kentaro Iwanaga, Noriyuki Ebi, Akihiro Nishiyama, Kazuhiro Yatera, Shoichi Kuyama, Minoru Fukuda, Sunao Ushijima, Hitomi Umeguchi, Daijiro Harada, Kosuke Kashiwabara, Takayuki Suetsugu, Nobukazu Fujimoto, Fumihiro Tanaka, Hidetaka Uramoto, Chiharu Yoshii, Katsumi Nakatomi, Genju Koh, Nobuhiko Seki, Keisuke Aoe, Kaname Nosaki, Koji Inoue, Ayako Takamori, Atsushi Kawaguchi
Published 2021-06-01

High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib

by Atsushi Osoegawa, MD, PhD, Masafumi Yamaguchi, MD, PhD, Tomomi Nakamura, MD, PhD, Ryotaro Morinaga, MD, Kentaro Tanaka, MD, PhD, Kosuke Kashiwabara, MD, PhD, Takashi Miura, MD, PhD, Takayuki Suetsugu, MD, PhD, Taishi Harada, MD, PhD, Tatsuma Asoh, MD, PhD, Kenichi Taguchi, MD, PhD, Kazuki Nabeshima, MD, PhD, Junji Kishimoto, MA, Kazuko Sakai, PhD, Kazuto Nishio, MD, PhD, Kenji Sugio, MD, PhD
Published 2021-07-01